Skip to search formSkip to main contentSkip to account menu

Daunorubicin

Known as: Daunorubicine, Daunomycin, DNM 
An anthracycline antineoplastic antibiotic with therapeutic effects similar to those of doxorubicin. Daunorubicin exhibits cytotoxic activity through… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Purpose CPX-351 is a dual-drug liposomal encapsulation of cytarabine and daunorubicin that delivers a synergistic 5:1 drug ratio… 
Highly Cited
2009
Highly Cited
2009
BACKGROUND A complete remission is essential for prolonging survival in patients with acute myeloid leukemia (AML). Daunorubicin… 
Review
2004
Review
2004
The clinical use of anthracyclines like doxorubicin and daunorubicin can be viewed as a sort of double-edged sword. On the one… 
Highly Cited
1998
Highly Cited
1998
  • L. Doyle, W. Yang, D. Ross
  • Proceedings of the National Academy of Sciences…
  • 1998
  • Corpus ID: 12757042
MCF-7/AdrVp is a multidrug-resistant human breast cancer subline that displays an ATP-dependent reduction in the intracellular… 
Highly Cited
1997
Highly Cited
1997
Compared with younger patients, elderly patients with acute myeloid leukemia (AML) respond poorly to conventional chemotherapy… 
Highly Cited
1982
Highly Cited
1982
We have used equilibrium dialysis and fluorescence and absorbance titration to study the interaction of daunomycin with DNA. Our… 
Highly Cited
1973
Highly Cited
1973
Daunorubicin induces complete remissions in about 50% of patients with acute promyelocytic leukemia. The median duration of these…